The activity of supported vanadium oxide catalysts for the selective reduction of NO with ammonia

The activities of monolayer V2O5 catalysts for the selective reduction of NO with NH3 are compared with those of commercial available catalysts containing V and/or W. From steady state and pulse experiments it can be concluded that the reduction of surface sites proceeds either by NH3 + NO or by NH3 alone. The reoxidation of the reduced sites occurs by gaseous oxygen or NO. The experimental reaction stoichiometry can be explained in terms of suitable combinations of these four reactions

Structure and reactivity of titania-supported oxides. Part 1: vanadium oxide on titania in the sub- and super-monolayer regions

Vanadium oxide has been deposited on TiO2 (washed anatase, 10 m2g−1; Degussa P-25, 55 ±3 m2g−1; Eurotitania, 46 m2g−1) by aqueous impregnation of (NH4)2[VO(C2O4)2] and by reaction with VOCl3, VO(OR)3 (R=iBu) and VO(acac)2 in organic solvents. Single applications of the last tree reagents form not more than a monolayer of vanadium oxide VOx, a monolayer being defined as 0.10 wt.% V2O5 per m2 of surface. When less than about four monolayers of VOx are present, there is in most cases only a single TPR peak: Tmax values, which increase with V2O5 content, are almost independent of the method used but vary slightly with the support (P-25 < Eurotitania < washed anatase). The 995 cm−1 band, characteristic of V&z.dbnd;O in V2O5, only appears when more than a monolayer of VOx is present.\ud \ud In the sub-monolayer region, VOx is best formulated as an oxohydroxy species bonded to two surface oxygens. As the V2O5 content is increased, layers of disordered V2O5 are formed on limited areas of the surface, but crystalline V2O5 only occurs, probably on top of the disordered V2O5, when the V2O5 content exceeds about four monolayers, and takes the form of acicular crystals exposing only planes perpendicular to the a and b axes

The preparation and properties of lanthanum-promoted nickel-alumina catalysts:Structure of the precipitates

Precursors of La-promoted Ni-alumina catalysts have been prepared by precipitation from their nitrate solutions at pH 7 using solutions of NH4HCO3, Na2CO3 or K2CO3. The preparation was carried out either by coprecipitation from a mixed salt solution or by sequential precipitation of Al3+, La3+ and Ni2+ in succession. In the absence of promoter, the precipitate with Ni/Al ratio of 2.5 is of the pyroaurite structure and has the composition Ni5Al2(OH)14CO3.4H2O. Two types of lanthanum-containing precipitate were made in which either extra La was added (Ni/Al kept constant at 2.5) or the proportion Ni/(Al+La) was kept constant at 2.5. The majority of these precipitates were single compounds which also had the pyroaurite structure. At high La contents, the series in which La is added gives separation of the compounds La2O(CO3)2 and LaONO3 in addition to the layer structure; with the series in which the La is substituted for Al, all the samples appeared to have the pyroaurite structure, even one in which no Al was present. The sequential precipitation route yields smaller crystallites than does coprecipitation. Materials precipitated with NH4HCO3 in all cases contained NH4NO3 while those precipitated with Na2CO3 gave inclusion of NaNO3. In both cases, the presence of the nitrates causes a decrease of crystallinity of the layer compound. Potassium is not included in the precipitate in any of the samples examined. A model is presented for the structure of the lanthanum-containing precipitates

Transcriptional Profiling of Human Familial Longevity Indicates a Role for ASF1A and IL7R

The Leiden Longevity Study consists of families that express extended survival across generations, decreased morbidity in middle-age, and beneficial metabolic profiles. To identify which pathways drive this complex phenotype of familial longevity and healthy aging, we performed a genome-wide gene expression study within this cohort to screen for mRNAs whose expression changes with age and associates with longevity. We first compared gene expression profiles from whole blood samples between 50 nonagenarians and 50 middle-aged controls, resulting in identification of 2,953 probes that associated with age. Next, we determined which of these probes associated with longevity by comparing the offspring of the nonagenarians (50 subjects) and the middle-aged controls. The expression of 360 probes was found to change differentially with age in members of the long-lived families. In a RT-qPCR replication experiment utilizing 312 controls, 332 offspring and 79 nonagenarians, we confirmed a nonagenarian specific expression profile for 21 genes out of 25 tested. Since only some of the offspring will have inherited the beneficial longevity profile from their long-lived parents, the contrast between offspring and controls is expected to be weak. Despite this dilution of the longevity effects, reduced expression levels of two genes, ASF1A and IL7R, involved in maintenance of chromatin structure and the immune system, associated with familial longevity already in middle-age. The size of this association increased when controls were compared to a subfraction of the offspring that had the highest probability to age healthily and become long-lived according to beneficial metabolic parameters. In conclusion, an “aging-signature” formed of 21 genes was identified, of which reduced expression of ASF1A and IL7R marked familial longevity already in middle-age. This indicates that expression changes of genes involved in metabolism, epigenetic control and immune function occur as a function of age, and some of these, like ASF1A and IL7R, represent early features of familial longevity and healthy ageing

The implicitome: A resource for rationalizing gene-disease associations

High-throughput experimental methods such as medical sequencing and genome-wide association studies (GWAS) identify increasingly large numbers of potential relations between genetic variants and diseases. Both biological complexity (millions of potential gene-disease associations) and the accelerating rate of data production necessitate computational approaches to prioritize and rationalize potential gene-disease relations. Here, we use concept profile technology to expose from the biomedical literature both explicitly stated gene-disease relations (the explicitome) and a much larger set of implied gene-disease associations (the implicitome). Implicit relations are largely unknown to, or are even unintended by the original authors, but they vastly extend the reach of existing

Whole Grain Wheat Consumption Affects Postprandial Inflammatory Response in a Randomized Controlled Trial in Overweight and Obese Adults with Mild Hypercholesterolemia in the Graandioos Study

BACKGROUND: Whole grain wheat (WGW) consumption is associated with health benefits in observational studies. However, WGW randomized controlled trial (RCT) studies show mixed effects. OBJECTIVES: The health impact of WGW consumption was investigated by quantification of the body's resilience, which was defined as the "ability to adapt to a standardized challenge." METHODS: A double-blind RCT was performed with overweight and obese (BMI: 25-35 kg/m2) men (n = 19) and postmenopausal women (n = 31) aged 45-70 y, with mildly elevated plasma total cholesterol (>5 mmol/L), who were randomly assigned to either 12-wk WGW (98 g/d) or refined wheat (RW). Before and after the intervention a standardized mixed-meal challenge was performed. Plasma samples were taken after overnight fasting and postprandially (30, 60, 120, and 240 min). Thirty-one biomarkers were quantified focusing on metabolism, liver, cardiovascular health, and inflammation. Linear mixed-models evaluated fasting compared with postprandial intervention effects. Health space models were used to evaluate intervention effects as composite markers representing resilience of inflammation, liver, and metabolism. RESULTS: Postprandial biomarker changes related to liver showed decreased alanine aminotransferase by WGW (P = 0.03) and increased β-hydroxybutyrate (P = 0.001) response in RW. Postprandial changes related to inflammation showed increased C-reactive protein (P = 0.001), IL-6 (P = 0.02), IL-8 (P = 0.007), and decreased IL-1B (P = 0.0002) in RW and decreased C-reactive protein (P < 0.0001), serum amyloid A (P < 0.0001), IL-8 (P = 0.02), and IL-10 (P < 0.0001) in WGW. Health space visualization demonstrated diminished inflammatory (P < 0.01) and liver resilience (P < 0.01) by RW, whereas liver resilience was rejuvenated by WGW (P < 0.05). CONCLUSIONS: Twelve-week 98 g/d WGW consumption can promote liver and inflammatory resilience in overweight and obese subjects with mildly elevated plasma cholesterol. The health space approach appeared appropriate to evaluate intervention effects as composite markers. This trial was registered at www.clinicaltrials.gov as NCT02385149.</p